Related Experiment Videos
Drug resistance molecules: lessons from oncology
George L Scheffer1, Rik J Scheper
1Department of Pathology, Free University Medical Center, Amsterdam, The Netherlands.
Abstract:
Tumour cell insensitivity to anticancer drugs frequently appears as multidrug resistance (MDR), associated with overexpression of one or more of a set of at least 10 different molecules, causing reduced drug levels at the intracellular target sites. They include transmembrane transporter proteins such as P glycoprotein, MRP1-9 and BCRP. In addition, the lung-resistance protein, recently identified as the major vault protein, has been associated with MDR. We have generated monoclonal antibodies that specifically recognize most of these proteins, which we are using to try to identify their roles in clinical drug resistance, and also to explore their occurrence in normal human tissues and physiology. Both types of studies will also provide further insights into the molecular features of drugs associated with distinct MDR transporters.
Insights
Researchers developed monoclonal antibodies to study multidrug resistance (MDR) in cancer. These antibodies target proteins like P-glycoprotein and BCRP, aiming to understand their role in drug resistance and normal physiology.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
- MDR is often linked to the overexpression of specific transporter proteins that reduce intracellular drug concentrations.
Purpose of the Study:
- To generate monoclonal antibodies against key MDR-associated proteins.
- To investigate the role of these proteins in clinical drug resistance.
- To explore the presence and function of these proteins in normal human tissues.
Main Methods:
- Development of monoclonal antibodies targeting MDR-associated proteins (e.g., P-glycoprotein, MRPs, BCRP, lung-resistance protein/major vault protein).
- Application of antibodies in studies of clinical drug resistance.
- Immunohistochemical analysis of normal human tissues.
Main Results:
- Successfully generated monoclonal antibodies recognizing multiple MDR-associated proteins.
- Antibodies are being used to elucidate the specific roles of these proteins in cancer drug resistance.
- Initial studies explore the expression patterns of these proteins in normal human physiology.
Conclusions:
- Monoclonal antibodies provide a valuable tool for studying MDR.
- Further research will clarify the contribution of distinct MDR transporters to clinical resistance and normal biological functions.
- Understanding these molecular mechanisms may lead to improved cancer therapies.